Search

Search results

399 results found

Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment.

Gelfand, Joel M, Alexa B Kimball, Eliot N Mostow, Chiun-Fang Chiou, Vaishali Patel, Amy Xia, Bruce Freundlich, and Seth R Stevens. 2008. “Patient-Reported Outcomes and Health-Care Resource Utilization in Patients With Psoriasis Treated With Etanercept: Continuous versus Interrupted Treatment.”. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 11 (3): 400-7.

Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory.

Gordon, K B, A B Kimball, D Chau, H N Viswanathan, J Li, D A Revicki, G Kricorian, and B G Ortmeier. 2014. “Impact of Brodalumab Treatment on Psoriasis Symptoms and Health-Related Quality of Life: Use of a Novel Patient-Reported Outcome Measure, the Psoriasis Symptom Inventory.”. The British Journal of Dermatology 170 (3): 705-15.